Kedalion Therapeutics
About:
Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.
Website: https://kedalionthera.com/
Top Investors: Novartis Venture Fund, Lagunita BioSciences
Description:
Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies for both new and existing indications. When compared to standard eye drops, Kedalion's proprietary AcuStream platform technology delivers topical drugs to the eye in a precise and accurate manner, enabling comparable effects with up to an 80% reduction in dose. AcuStream is a novel, digitally connected, electromechanical topical ocular delivery device that aims to fill a potential unmet need for a convenient, user-friendly device that reliably, accurately, and comfortably delivers topical ocular therapy with increased efficiency and patient comfort.
$5M
$1M to $10M
Menlo Park, California, United States
2015-01-01
info(AT)kedalionthera.com
Ehud Ivri, Mark Blumenkranz
1-10
2021-11-15
Private
© 2025 bioDAO.ai